|
|
Volumn 25, Issue 1, 2012, Pages
|
|
Meeting report from the 2011 international melanoma congress, Tampa, Florida
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (1H INDAZOL 4 YL) 6 (4 METHANESULFONYL 1 PIPERAZINYLMETHYL) 4 MORPHOLINOTHIENO[3,2 D]PYRIMIDINE;
5 AZA 2' DEOXYCYTIDINE;
ANTINEOPLASTIC AGENT;
B RAF KINASE INHIBITOR;
BETA CATENIN;
BEVACIZUMAB;
CHIR 265;
DACARBAZINE;
GDC 0973;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE;
GSK 1120212;
GSK 2118436;
HEAT SHOCK PROTEIN 90 INHIBITOR;
HYDROXYCHLOROQUINE;
IPILIMUMAB;
MDX 1106;
MELANIN;
MELANOCORTIN 1 RECEPTOR;
METFORMIN;
PACLITAXEL;
PROTEIN C JUN;
PROTEIN P53;
RAPAMYCIN;
TASISULAM;
TEMOZOLOMIDE;
TRANSCRIPTION FACTOR AP 1;
UNCLASSIFIED DRUG;
VELIPARIB;
VEMURAFENIB;
WNT PROTEIN;
XL 888;
ADOPTIVE CELL TRANSFER;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
AUTOPHAGY;
CANCER GROWTH;
CANCER IMMUNOLOGY;
CANCER RESISTANCE;
CANCER RISK;
CANCER STAGING;
CANCER SURVIVAL;
CANCER SUSCEPTIBILITY;
CELL CYCLE ARREST;
CELL CYCLE G2 PHASE;
CELL CYCLE M PHASE;
COLORECTAL CARCINOMA;
CONFERENCE PAPER;
DIARRHEA;
DRUG DOSE ESCALATION;
DRUG ERUPTION;
DRUG POTENTIATION;
DRUG RESPONSE;
DRUG WITHDRAWAL;
EPIGENETICS;
FATIGUE;
GENE MUTATION;
GENE OVEREXPRESSION;
GLYCOLYSIS;
HUMAN;
IMMUNOTHERAPY;
KIDNEY CARCINOMA;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
MELANOCYTE;
MELANOGENESIS;
MELANOMA;
MELANOSIS;
METASTASIS;
NEUTROPENIA;
NEVUS;
NONHUMAN;
ONCOGENE;
OVERALL SURVIVAL;
PERIPHERAL EDEMA;
PHASE 3 CLINICAL TRIAL (TOPIC);
PHENOTYPE;
PROGRESSION FREE SURVIVAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SENESCENCE;
SENTINEL LYMPH NODE BIOPSY;
SIGNAL TRANSDUCTION;
SKIN CARCINOMA;
SQUAMOUS CELL CARCINOMA;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TRANSCRIPTION REGULATION;
TUMOR ASSOCIATED LEUKOCYTE;
ULTRAVIOLET RADIATION;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 84992240354
PISSN: 17551471
EISSN: 1755148X
Source Type: Journal
DOI: 10.1111/j.1755-148X.2011.00943.x Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|
